Javascript must be enabled to continue!
Analysis of clinical characteristics, diagnosis and treatment status of hospitalized patients with chronic heart failure in Xinjiang,China
View through CrossRef
Abstract
Purpose
To investigate and analyze the demographic data, clinical characteristics, treatment and prognosis of hospitalized patients with chronic heart failure (CHF) in Xinjiang.
Methods
The data included in this study are the subgroup data from the Xinjiang of the China Heart Failure Center Registration Study. From January 1, 2018 to September 1, 2020, 7677 CHF patients who meet the CHF diagnostic criteria and have complete clinical data will be treated as the research objects. Collect selected demographic data, heart failure risk factors, heart failure etiology, laboratory and examination results, medication use and prognosis information.
Results
(1)The causes of CHF are: coronary atherosclerotic heart disease (65.57%), dilated cardiomyopathy (11.05%), hypertension (9.01%) and valvular heart disease (8.7%).༈2༉A total of 78 CHF patients (1.00%) died in the hospital during hospitalization. A total of 512 CHF deaths (6.8%) occurred within 12 months of discharge.༈3༉HFpEF patients are older, the proportion of women is the highest, and the proportion of patients with CHF comorbidities is the highest (P < 0.05).༈4༉Although there was no significant difference in the standardized medications of CHF in the provincial and municipal tertiary hospitals, the proportion of pacing intervention and coronary revascularization in the provincial tertiary hospitals was higher than that in the municipal tertiary hospitals (P < 0.05).
Conclusion
The main cause of CHF in Xinjiang is coronary heart disease, and patients with different types of CHF have different clinical characteristics. The mortality rate of CHF inside and outside the hospital is still high, and there is a certain gap between the treatment practice of CHF in Xinjiang and the treatment recommended by the guidelines. It is necessary to establish and improve a standardized, individualized, and standardized diagnosis and treatment system for CHF in Xinjiang.
Research Square Platform LLC
Title: Analysis of clinical characteristics, diagnosis and treatment status of hospitalized patients with chronic heart failure in Xinjiang,China
Description:
Abstract
Purpose
To investigate and analyze the demographic data, clinical characteristics, treatment and prognosis of hospitalized patients with chronic heart failure (CHF) in Xinjiang.
Methods
The data included in this study are the subgroup data from the Xinjiang of the China Heart Failure Center Registration Study.
From January 1, 2018 to September 1, 2020, 7677 CHF patients who meet the CHF diagnostic criteria and have complete clinical data will be treated as the research objects.
Collect selected demographic data, heart failure risk factors, heart failure etiology, laboratory and examination results, medication use and prognosis information.
Results
(1)The causes of CHF are: coronary atherosclerotic heart disease (65.
57%), dilated cardiomyopathy (11.
05%), hypertension (9.
01%) and valvular heart disease (8.
7%).
༈2༉A total of 78 CHF patients (1.
00%) died in the hospital during hospitalization.
A total of 512 CHF deaths (6.
8%) occurred within 12 months of discharge.
༈3༉HFpEF patients are older, the proportion of women is the highest, and the proportion of patients with CHF comorbidities is the highest (P < 0.
05).
༈4༉Although there was no significant difference in the standardized medications of CHF in the provincial and municipal tertiary hospitals, the proportion of pacing intervention and coronary revascularization in the provincial tertiary hospitals was higher than that in the municipal tertiary hospitals (P < 0.
05).
Conclusion
The main cause of CHF in Xinjiang is coronary heart disease, and patients with different types of CHF have different clinical characteristics.
The mortality rate of CHF inside and outside the hospital is still high, and there is a certain gap between the treatment practice of CHF in Xinjiang and the treatment recommended by the guidelines.
It is necessary to establish and improve a standardized, individualized, and standardized diagnosis and treatment system for CHF in Xinjiang.
Related Results
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Objective: To determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Abstract
Introduction
Immunoglobulin G4-related disease (IgG4-RD) is a recently identified immune-mediated condition that is debilitating and often overlooked. While IgG4-RD has be...
The Impact of IL28B Gene Polymorphisms on Drug Responses
The Impact of IL28B Gene Polymorphisms on Drug Responses
To achieve high therapeutic efficacy in the patient, information on pharmacokinetics, pharmacodynamics, and pharmacogenetics is required. With the development of science and techno...
Etiology and predictors of heart failure in pregnancy. Newer Insights from the M-PAC registry
Etiology and predictors of heart failure in pregnancy. Newer Insights from the M-PAC registry
Abstract
Background
Women with heart disease undergoing pregnancy is on the increase, along with an increasing cardiac contribut...
Current Perspectives on Cystic Echinococcosis: A Systematic Review
Current Perspectives on Cystic Echinococcosis: A Systematic Review
Abstract
Introduction: Hydatidosis, a zoonotic disease caused by the larval stage of Echinococcus granulosus, is a significant public health concern with notable economic impact. I...
Empagliflozin in the Real World: Strengthening Heart Failure Care in Pakistan
Empagliflozin in the Real World: Strengthening Heart Failure Care in Pakistan
Heart failure with reduced ejection fraction (HFrEF) remains a major clinical challenge worldwide and is a pressing public health issue in Pakistan. Patients here often present at ...
Treatment outcomes and associated factors among chronic ambulatory heart failure patients at Jimma Medical Center, South West Ethiopia: prospective observational study
Treatment outcomes and associated factors among chronic ambulatory heart failure patients at Jimma Medical Center, South West Ethiopia: prospective observational study
Abstract
Background
Heart failure has been one of the major causes of hospitalization across the world. Focusing on the treatment outcomes of ambula...

